BrightAccountsProduction v1.0.0 v1.0.0 2023-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The company is a holding company. 26 March 2024 1 1 NI670172 2023-12-31 NI670172 2022-12-31 NI670172 2021-12-31 NI670172 2023-01-01 2023-12-31 NI670172 2022-01-01 2022-12-31 NI670172 uk-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 NI670172 uk-curr:PoundSterling 2023-01-01 2023-12-31 NI670172 uk-bus:AbridgedAccounts 2023-01-01 2023-12-31 NI670172 uk-core:ShareCapital 2023-12-31 NI670172 uk-core:ShareCapital 2022-12-31 NI670172 uk-core:RetainedEarningsAccumulatedLosses 2023-12-31 NI670172 uk-core:RetainedEarningsAccumulatedLosses 2022-12-31 NI670172 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-12-31 NI670172 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2022-12-31 NI670172 uk-core:RestatedAmount uk-core:RetainedEarningsAccumulatedLosses 2022-12-31 NI670172 uk-bus:FRS102 2023-01-01 2023-12-31 NI670172 uk-core:CostValuation 2023-12-31 NI670172 2023-01-01 2023-12-31 NI670172 uk-bus:Director1 2023-01-01 2023-12-31 NI670172 uk-bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: NI670172
 
 
LS Health & Beauty Holdings Limited
 
Abridged Unaudited Financial Statements
 
for the financial year ended 31 December 2023
LS Health & Beauty Holdings Limited
DIRECTOR'S REPORT
for the financial year ended 31 December 2023

 
The director presents her report and the unaudited financial statements for the financial year ended 31 December 2023.
     
Director
The director who served during the financial year is as follows:
     
Ms. Linda Stinson
   
     
Statement of Director's Responsibilities
     
The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.
     
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the director is required to:
- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
     
___________________________
Ms. Linda Stinson
Director
     
26 March 2024



LS Health & Beauty Holdings Limited
ABRIDGED PROFIT AND LOSS ACCOUNT
for the financial year ended 31 December 2023
2023 2022
Notes £ £

Profit before taxation - -
 
Tax on profit - -
───────── ─────────
Profit for the financial year - -
    ═════════   ═════════



LS Health & Beauty Holdings Limited
Company Registration Number: NI670172
ABRIDGED BALANCE SHEET
as at 31 December 2023

2023 2022
Notes £ £
 
Fixed Assets
Investments 4 341,225 341,225
───────── ─────────
 
Current Assets
Debtors 50 50
───────── ─────────
Net Current Assets 50 50
───────── ─────────
Total Assets less Current Liabilities 341,275 341,275
═════════ ═════════
 
Capital and Reserves
Called up share capital 100 100
Retained earnings 341,175 341,175
───────── ─────────
Equity attributable to owners of the company 341,275 341,275
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
For the financial year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges her responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 26 March 2024
           
           
           
________________________________          
Ms. Linda Stinson          
Director          
           



LS Health & Beauty Holdings Limited
STATEMENT OF CHANGES IN EQUITY
as at 31 December 2023

Called up Retained Total
share earnings
capital
£ £ £
 
At 1 January 2022 100 341,175 341,275
───────── ───────── ─────────
At 31 December 2022 100 341,175 341,275
  ───────── ───────── ─────────
At 31 December 2023 100 341,175 341,275
  ═════════ ═════════ ═════════



LS Health & Beauty Holdings Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 31 December 2023

   
1. General Information
 
LS Health & Beauty Holdings Limited is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI670172. The registered office of the company is , Northern Ireland. The company is a holding company. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 31 December 2023 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention, except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Investments
Investments held as fixed assets are stated at cost less provision for any permanent diminution in value. Income from other investments together with any related tax credit is recognised in the profit and loss account in the financial year in which it is receivable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was:
 
  2023 2022
  Number Number
 
Employee 1 1
  ═════════ ═════════
       
4. Investments
  Other Total
  investments  
     
Investments £ £
Cost
 
At 31 December 2023 341,225 341,225
  ───────── ─────────
Net book value
At 31 December 2023 341,225 341,225
  ═════════ ═════════
At 31 December 2022 341,225 341,225
  ═════════ ═════════